150 related articles for article (PubMed ID: 9444979)
1. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1.
Prohászka Z; Német K; Csermely P; Hudecz F; Mezõ G; Füst G
Mol Immunol; 1997 Aug; 34(11):809-16. PubMed ID: 9444979
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of activation of the classical pathway of complement by human neutrophil defensins.
van den Berg RH; Faber-Krol MC; van Wetering S; Hiemstra PS; Daha MR
Blood; 1998 Nov; 92(10):3898-903. PubMed ID: 9808583
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
Ebenbichler CF; Thielens NM; Vornhagen R; Marschang P; Arlaud GJ; Dierich MP
J Exp Med; 1991 Dec; 174(6):1417-24. PubMed ID: 1744579
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41.
Hidvégi T; Prohászka Z; Ujhelyi E; Thielens NM; Dierich MP; Hampl H; Arlaud G; Nagy K; Füst G
Clin Exp Immunol; 1993 Dec; 94(3):490-3. PubMed ID: 8252810
[TBL] [Abstract][Full Text] [Related]
5. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology.
Stoiber H; Thielens NM; Ebenbichler C; Arlaud GJ; Dierich MP
Eur J Immunol; 1994 Feb; 24(2):294-300. PubMed ID: 7507842
[TBL] [Abstract][Full Text] [Related]
6. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.
Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
J Immunol; 1993 Dec; 151(11):6583-92. PubMed ID: 8245486
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120.
Stoiber H; Ebenbichler CF; Thielens NM; Arlaud GJ; Dierich MP
Mol Immunol; 1995 Apr; 32(5):371-4. PubMed ID: 7739575
[TBL] [Abstract][Full Text] [Related]
9. Importance of carbohydrate in the interaction of Tamm-Horsfall protein with complement 1q and inhibition of classical complement activation.
Rhodes DC
Immunol Cell Biol; 2006 Aug; 84(4):357-65. PubMed ID: 16594900
[TBL] [Abstract][Full Text] [Related]
10. HIV and complement: role of the complement system in HIV infection.
Marschang P; Ebenbichler CF; Dierich MP
Int Arch Allergy Immunol; 1994; 103(2):113-7. PubMed ID: 8292898
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the interaction between the immunodominant loop of the ectodomain of HIV-1 gp41 and human complement protein C1q.
Quinkal I; Hernandez JF; Chevallier S; Arlaud GJ; Vernet T
Eur J Biochem; 1999 Oct; 265(2):656-63. PubMed ID: 10504397
[TBL] [Abstract][Full Text] [Related]
14. Interaction of C1 with HIV-1.
Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
Behring Inst Mitt; 1993 Dec; (93):165-70. PubMed ID: 8172563
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
Su H; Boackle RJ
Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
[TBL] [Abstract][Full Text] [Related]
16. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of IgG and of a HIV gp41 peptide by the B chain and A chain globular head sequences of C1q, respectively.
Kojouharova MS; Panchev ID; Tchorbadjieva MI; Reid KB; Hoppe HJ
J Immunol; 1998 Oct; 161(8):4325-31. PubMed ID: 9780209
[TBL] [Abstract][Full Text] [Related]
18. Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41.
Marschang P; Krüger U; Ochsenbauer C; Gürtler L; Hittmair A; Bosch V; Patsch JR; Dierich MP
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):102-9. PubMed ID: 9052718
[TBL] [Abstract][Full Text] [Related]
19. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
20. Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies.
Koolwijk P; Boot JH; Griep R; Bast BJ
Mol Immunol; 1991 Jun; 28(6):567-76. PubMed ID: 1861677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
